The InSpectra™ StO2 Spot Check is a noninvasive tool to quickly and cost-effectively identify patients at risk for circulatory distress. Once identified to have low StO2, patients can then be continuously monitored with the InSpectra™ StO2 Tissue Oxygenation Monitor. Used together, these two products help reduce the time to critical actions and help identify the endpoints of resuscitation.
InSpectraTM StO2 Spot Check
Quick assessment helps identify
at risk patients in seconds.
Low StO2 is associated with high
StO2 - guided resuscitation,
improved outcomes, and reduced
costs (i.e., less blood).3,4
Low StO2 occured in 20–30% of
critically ill patients having non-
alarming vital signs.5,6
InSpectraTM StO2 Monitor
Continuous monitor tracks a
patient's response to interventions.
Assist in detecting and treating occult
hypoperfusion and reduce time to
Monitor response to vasopressors and
Help in reducing ICU days.8
1 Cohn SM, et al. J Trauma. 2007;62(1):44-55.
2 Leone M, et al. Anesthesiology. 2009;111:366-371.
3 Loukas A, et al.
31st ISICEM; 22-25 March 2011; Brussels, Belgium.
4 Miner J, et al. Crit Care
5 Ardolic B, et al.
Emerg Med. 2010;56(3):S131.
6 Veening A, et al.
7 Georger, J. F.,
et al (2007). Int
33(Supp 2): S166.
8 Haas B, et al.
AAST 66th Annual Meeting; September 27-29, 2007; Las Vegas, NV.
Clinical signs confounded by:
Critical Care Patients
Nonalarming clinical signs
Difficult to diagnose/treat